Competition aimed at revealing new insights in cancer research and treatments to accelerate progress toward a cure
PHILADELPHIA, PA (October 5, 2016) — Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters today announced its third place win with Georgetown University in the USPTO Cancer Moonshot Challenge held by the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO).
Launched by the USPTO in August, the competition aimed to reveal new insights from patent data in support of the goals of the National Cancer Moonshot initiative: to accelerate the development of patient-focused cancer treatments, increase patient access to clinical trials and therapies and align public-private policies and investment to improve the ability to prevent cancer and detect it at an early stage. Participants built visualizations leveraging a dataset developed by the USPTO, to reveal trends and gain insights to guide public policy and research in cancer.
Clarivate, with Georgetown Lombardi Comprehensive Cancer Center, developed the Innovation Visualization and Understanding for Cancer Tool (Cancer InnovationVU). The interactive resource, built on data integrated in the ScienceWire® platform, combines timelines of patenting and funding with data on the epidemiology of cancer in the United States. The platform was used by the NIH, NSF and others and facilitates evaluation and decision-making for science. Users of Cancer InnovationVU explore relationships among patents, research funding and cancer incidence and mortality. USPTO acknowledged Cancer InnovationVU for illustrating how “the epidemiology of cancer mortality relates to patenting and funding timelines.”
“We are delighted to be recognized by the USPTO along with the Georgetown Lombardi Comprehensive Cancer Center,” said Chris McKenna, general manager, Discovery Science at Clarivate. “This challenge demonstrates the value in democratizing data, using analytics to reveal new insights into cancer trends and in difficult to study relationships across data otherwise operating on different timescales.”
“We need to leave no stone unturned as we pursue new approaches in preventing, diagnosing and treating cancer,” said team member Chiranjeev Dash, M.B.B.S., Ph.D., associate professor of oncology at Georgetown Lombardi. “The success of the National Cancer Moonshot initiative will depend on our ability to forge collaborations between academia, industry and government to not only generate new data, but to more effectively mine the high-quality data already available to us.”
The award-winning team consisted of Di Cross, Director of Research Analytics and Eugene Rakhmatulin, Senior Director of Enabling Technologies & Informatics Delivery, and Dash from Georgetown Lombardi.
ClarivateTM Analytics accelerates the pace of innovation by providing trusted insights and analytics to customers around the world, enabling them to discover, protect and commercialize new ideas, faster. Formerly the Intellectual Property and Science business of Thomson Reuters, we’ve been assisting our customers for over 60 years. Now as an independent company with over 4,000 employees, operating in more than 100 countries around the world, we remain expert, objective and agile. For more information, please visit us at Clarivate.com.
About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center is designated by the National Cancer Institute as a comprehensive cancer center — the only cancer center of its kind in the Washington, DC area. A part of Georgetown University Medical Center and MedStar Georgetown University Hospital, Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Connect with Georgetown Lombardi on Facebook (Facebook.com/GeorgetownLombardi) and Twitter (@LombardiCancer).
About Georgetown University Medical Center
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health. Connect with GUMC on Facebook (Facebook.com/GUMCUpdate), Twitter (@gumedcenter) and Instagram (@gumedcenter).